First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes…
Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month…
DRAPER, Utah, May 09, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health…
New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following…
Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that…
ATHENS, Ga., May 9, 2025 /PRNewswire/ -- With Mother's Day right around the corner, the Georgia Maternal Health Task Force…
GLEN ALLEN, Va., May 9, 2025 /PRNewswire/ -- Hamilton Beach Brands Holding Company (NYSE: HBB) (the Company) today announced that the…
SCHAUMBURG, Ill., May 9, 2025 /PRNewswire/ -- For the sixth year in a row, Auguste Escoffier School of Culinary Arts…
Spartanburg, South Carolina--(Newsfile Corp. - May 9, 2025) - Dr. Christina Rahm, renowned scientist, humanitarian, and founder of Merci Dupre…
Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly…